What is Neuropace, Inc.'s cost not yet recognized?

Neuropace, Inc. (NPCE) reported cost not yet recognized of $18.4M in Q1 2026.

How has Neuropace, Inc.'s cost not yet recognized changed year-over-year?

Neuropace, Inc.'s cost not yet recognized decreased by 13.2% year-over-year, from $21.2M to $18.4M.

What is the long-term trend for Neuropace, Inc.'s cost not yet recognized?

Over 3 years (2022 to 2025), Neuropace, Inc.'s cost not yet recognized has grown at a -7.2% compound annual growth rate (CAGR), from $19.8M to $15.8M.

Neuropace, Inc. NPCE Cost not yet recognized

Cost not yet recognized at other companies

L3Harris TechnologiesLHX

$20M0.0%

Frequency ElectronicsFEIM

$1.05M+44.8%

AmetekAME

$21.9M-7.2%

NioCorp Developments Ltd.NB

$4K—

NVE CorporationNVEC

$854.75—

CNB FinancialCCNE

$0—

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s cost not yet recognized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s cost not yet recognized?: Neuropace, Inc. (NPCE) reported cost not yet recognized of $18.4M in Q1 2026.
How has Neuropace, Inc.'s cost not yet recognized changed year-over-year?: Neuropace, Inc.'s cost not yet recognized decreased by 13.2% year-over-year, from $21.2M to $18.4M.
What is the long-term trend for Neuropace, Inc.'s cost not yet recognized?: Over 3 years (2022 to 2025), Neuropace, Inc.'s cost not yet recognized has grown at a -7.2% compound annual growth rate (CAGR), from $19.8M to $15.8M.